We are live on ! Find out more
DSCI

Derma Sciences, Inc. Common Stock (DE)
DSCI

Delisted

DSCI was delisted on the 23rd of February, 2017.

Back to rankings

73 hedge funds and large institutions have $251M invested in Derma Sciences, Inc. Common Stock (DE) in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 19

36% more call options, than puts

Call options by funds: $458K | Put options by funds: $337K

17% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 12

3% more funds holding

Funds holding: 71 → 73 (+2)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

9% less capital invested

Capital invested by funds: $274M → $251M (-$23.4M)

Holders
73
Holders Change
+2
Holders Change %
+2.82%
% of All Funds
2.1%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
14
Increased
29
Reduced
19
Closed
12
Calls
$458K
Puts
$337K
Net Calls
+$121K
Net Calls Change
+$121K

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$6.36M
2
CCM
Consonance Capital Management
New York
+$5.75M
3
SM
Senvest Management
New York
+$4.24M
4
GPP
Great Point Partners
Connecticut
+$2.29M
5
DM
Deerfield Management
New York
+$2.24M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$17M
2
MHP
Manatuck Hill Partners
Connecticut
-$3.36M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.32M
4
Wells Fargo
Wells Fargo
California
-$2.91M
5
AAP
Ardsley Advisory Partners
Connecticut
-$2.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
26
Adage Capital Partners
Massachusetts
$1.73M -$1.27M -123,661 -45%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$1.44M +$25.7K +2,504 +2%
RAM
28
Roanoke Asset Management
New Jersey
$1.3M +$815K +79,376 +242%
TCIM
29
TIAA CREF Investment Management
New York
$1.17M +$399K +38,861 +63%
EIM
30
Essex Investment Management
Massachusetts
$1.08M -$239K -23,295 -20%
BIM
31
BlackRock Investment Management
Delaware
$850K +$52.7K +5,135 +8%
Fidelity International
32
Fidelity International
Bermuda
$802K +$712K +69,412 New
CB
33
Commerce Bank
Missouri
$762K – – –
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$653K – – –
RA
35
Royce & Associates
New York
$636K – – –
Deutsche Bank
36
Deutsche Bank
Germany
$523K +$37.7K +3,674 +9%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$478K +$46.2K +4,500 +12%
SAM
38
Symphony Asset Management
California
$416K +$369K +35,983 New
TA
39
Teachers Advisors
New York
$355K +$56.4K +5,494 +22%
Charles Schwab
40
Charles Schwab
California
$330K – – –
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$290K +$43K +4,190 +20%
Allianz Asset Management
42
Allianz Asset Management
Germany
$237K -$21.7K -2,115 -9%
AAP
43
Ardsley Advisory Partners
Connecticut
$231K -$2.57M -250,000 -93%
U
44
UBS
Switzerland
$213K +$42.3K +4,124 +29%
NFA
45
Nationwide Fund Advisors
Ohio
$199K +$22.6K +2,201 +15%
MLICM
46
Metropolitan Life Insurance Company (MetLife)
New York
$197K – – –
State Board of Administration of Florida Retirement System
47
State Board of Administration of Florida Retirement System
Florida
$191K +$7.04K +686 +4%
AHC
48
Anderson Hoagland & Co
Missouri
$173K – – –
AIG
49
American International Group
New York
$171K +$55.4K +5,401 +57%
Millennium Management
50
Millennium Management
New York
$168K +$149K +14,519 New
1
2
3 4

DSCI Hedge Fund Activity: Q2 2014 in Review

73 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q2 2014, worth a combined $251M — down 8.5% from $274M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new DSCI positions and 12 closed out — a net gain of 2 holders — while 29 added to existing stakes and 19 trimmed.

The largest buyer was HealthCor Management, adding an estimated $6.36M. The largest seller was RA Capital Management, exiting entirely with an estimated $17M sold.

  • 73 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q2 2014, up from 71 in Q1 2014.
  • Funds reported $251M of Derma Sciences, Inc. Common Stock (DE) stock for Q2 2014, down 8.5% quarter-over-quarter.
  • 14 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q2 2014 and 12 closed out, a net change of +2 holders.
  • The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q2 2014 was HealthCor Management, an estimated $6.36M added.
  • The largest Derma Sciences, Inc. Common Stock (DE) seller in Q2 2014 was RA Capital Management, an estimated $17M sold.

Based on aggregated 13F filings for Q2 2014.